Biosimilar drugs, also known simply as biosimilars, are highly similar to an already approved biological product, known as the reference product. They have no clinically meaningful differences in terms of safety and effectiveness from the reference product. Biosimilars are typically used to treat conditions such as autoimmune diseases, cancer, and other chronic conditions.
